...
首页> 外文期刊>Circulation journal >Pediatric radiofrequency catheter ablation: sedation methods and success, complication and recurrence rates.
【24h】

Pediatric radiofrequency catheter ablation: sedation methods and success, complication and recurrence rates.

机译:小儿射频导管消融:镇静方法及成功率,并发症及复发率。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: There remains to be issues regarding radiofrequency catheter ablation (RFCA) in pediatric patients that are different to those involving adults. This study was performed to determine the efficacy and safety of RFCA in pediatric patients. METHODS AND RESULTS: During the period from 1992 to 2003, 2,734 patients underwent RFCA and 131 pediatric patients who were < or =15 years old (70 males, mean age 12.0+/-3.1 years) were analyzed, retrospectively. The number of accessory pathways (APs) mediating atrioventricular re-entrant tachycardia was 93 (71.4%) and atrioventricular nodal re-entrant tachycardia (AVNRT) was 27 (20.5%). The most common indications for the RFCA were the ;patient's choice' in 94 (71.2%) and 'medically refractory tachycardia' in 29 (22.0%). The age-related indication of the ;patient's choice' was 80.4% (82 of 102) for those >10 years old and 40.0% (12 of 30) for those < or =10 years old (p=0.01). RFCA was performed without sedation in 87.3% (89 of 102) of the subjects >10 years old as compared to 20.0% (6 of 30) of those < or =10 years old (p=0.01). The success rate was 92.8% (90 of 97 APs) for the ablation of APs, and 96.3% (26 of 27) for that of AVNRT. The overall complication rate was 3.8% (5 of 131). During a mean follow-up duration of 13.1+/-2.5 months, the freedom of recurrence was 87.8% (79 of 90) for the arrhythmia associated with APs and 92.3% (24 of 26) for AVNRT. CONCLUSION: RFCA in pediatric patients had a good success rate with acceptable recurrence and complication rates when compared to adult patient results. Therefore, RFCA could be considered as the first line of therapy for arrhythmias with concealed and manifested APs and AVNRT in pediatric patients.
机译:背景:与成人患者不同,小儿患者的射频导管消融(RFCA)仍然存在问题。进行这项研究是为了确定RFCA在小儿患者中的疗效和安全性。方法和结果:回顾性分析了1992年至2003年期间接受RFCA的2734例患者和年龄小于或等于15岁的131例儿科患者(男性70例,平均年龄12.0 +/- 3.1岁)。介导房室折返性心动过速的辅助途径(AP)数量为93(71.4%),房室结折返性心动过速(AVNRT)为27(20.5%)。 RFCA的最常见指征是94例中的“患者选择”(占71.2%)和29例中的“难治性心动过速”(占22.0%)。年龄相关的“患者选择”指征对于> 10岁的患者为80.4%(102个中的82个),对于<或= 10岁的患者为40.0%(30个中的12个)(p = 0.01)。在10岁以上的受试者中,有87.3%(102名患者中的89名)在没有镇静的情况下进行了RFCA,而在10岁或10岁以上的受试者中,有20.0%(30名中的6名)(p = 0.01)。消融AP的成功率为92.8%(97个AP中的90个),AVNRT的成功率为96.3%(27个中的26个)。总体并发症发生率为3.8%(131例中的5例)。在平均13.1 +/- 2.5个月的随访期间,与AP相关的心律失常的复发自由率为87.8%(90中的79),而AVNRT为92.3%(26中的24)。结论:与成年患者相比,小儿患者的RFCA成功率高,复发率和并发症发生率均可接受。因此,RFCA可以被认为是小儿患者隐匿性和明显性AP和AVNRT治疗心律不齐的第一线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号